About Carmentix Pte Ltd.

Carmentix enables early prevention of preterm birth through prediction. It develops a novel biomarker prognostic panel for preterm birth. They reduce the number of preterm birth in the global setting by establishing biomolecular tools that will alert clinicians for the risk of preterm birth weeks before symptoms occur.

Company Highlights
Year Founded

2015

icon-altEmployees

1

Location (HQ)

SGP

Since Last Funding

9 years 2 months

Monthly Website Visitors

2.4K

icon-altTotal Investment Amt

$3.5M

Last Funding Round

Series Unknown

icon-altMoM Headcount Growth

-47.62%

icon-altYoY Headcount Growth

-64.52%

Key Metrics

Senior Hires

NameLinkedin ProfilePositionDate Joined
John Doehttps://www.linkedin.com/in/johndoeCEOCEO
Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
Get API access to complete private company database with growth metrics from 15 sources

Similar Companies

Biotechnology Research

Health Diagnostics